Elevate Health vs MEDVi: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher & Publisher

Reviewed & updated August 14, 2026 · Cites primary sources (FDA, NEJM, CMS) · Not medical advice

54 providers verified independently·Independent research·How we rank →

Short answer: Elevate Health scores higher on our rubric, 7.2/10 against 5.7/10. Full reasoning, pricing and the cases where the other one wins are below.

Visit MEDVi - $179 first month, then $299/mo →or find your match

Elevate Health beats MEDVi overall, scoring 7.2/10 vs 5.7/10. Published pricing is not a like-for-like monthly comparison: Elevate Health is from $233/mo; MEDVi is $179 first month, then $299/mo. Choose Elevate Health for users who want financing options and free lab work with their glp-1 program. Choose MEDVi for users who want both oral and injectable compounded options in one telehealth program.

A side-by-side look at Elevate Health and MEDVi to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Higher Rated

Elevate Health

#39 of 54

7.2/10

Affordable compounded GLP-1 provider with financing options and complimentary lab work for qualifying patients.

Visit Elevate Health

MEDVi

#46 of 54

5.7/10

MEDVi offers oral and injectable compounded GLP-1 care. Semaglutide is $179 for month one and $299 for refills. Trustpilot is 4.4/5 across roughly 11,000 reviews, while BBB is F/not accredited. FDA warning letter #721455 concerns misleading labeling and marketing, not an allegation that the medication was unsafe.

Visit MEDVi

Feature	Elevate Health	MEDVi
Why each one	Includes free blood work and buy-now-pay-later financing (Affirm, Klarna, Afterpay), making GLP-1 accessible for patients who can't pay upfront.	Oral and injectable compounded formats in one program, with micro-dosing options and a path to FDA-approved brand medication.
Our Score	7.2/10	5.7/10
Headline Price	from $233/mo	$179 first month, then $299/mo
Medication Type	Both	Both
Insurance Accepted	No	No
Best For	Users who want financing options and free lab work with their GLP-1 program	Users who want both oral and injectable compounded options in one telehealth program
Watch out for	Promo-dependent pricing, standard tirzepatide is $449/mo without discount, nearly double the promo price	FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication
Ranking	#39	#46
Get started	Visit Elevate Health	Visit MEDVi

Pros & Cons Compared

Elevate Health

Pros

+Oral semaglutide from $114/mo, one of the lowest prices for any form of semaglutide in the market
+Free blood work included with all GLP-1 programs for baseline health assessment and monitoring
+Buy-now-pay-later financing via Affirm, Klarna, and Afterpay, removes the upfront cost barrier
+Medications sourced from FDA-registered 503B outsourcing facilities, stricter oversight than standard compounding

Cons

−Promo-dependent pricing, standard tirzepatide is $449/mo without discount, nearly double the promo price
−Select state availability only, not available nationwide
−Trustpilot rating flagged for potential review solicitation, verify independently

MEDVi

Pros

+One of the few compounded providers offering both oral tablets and injectable semaglutide
+Micro-dosing options available, can start at sub-standard doses for patients concerned about side effects
+Sleek onboarding experience with clear progress tracking through their patient portal
+$179 covers the first month of compounded semaglutide on the current Katalys landing, including clinician review, medication and shipping

Cons

−FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication
−Its third-party records conflict: 4.4/5 across roughly 11,000 Trustpilot reviews, but an F and no accreditation at the BBB
−The $179 semaglutide price is introductory; the current Katalys landing says refills are $299/mo, making the first-year total $3,468 rather than $2,148
−Brand-name Wegovy and Zepbound paths add a $99 membership plus the medication cost, which the current landing does not publish; availability can change
−No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms

Our Verdict

Elevate Health edges out MEDVi with a score of 7.2/10 vs 5.7/10. Published pricing is not a like-for-like monthly comparison: Elevate Health is from $233/mo; MEDVi is $179 first month, then $299/mo.